Seres Therapeutics (MCRB)
(Delayed Data from NSDQ)
$0.83 USD
-0.08 (-9.10%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $0.88 +0.05 (5.77%) 5:30 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.24 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | 21.43% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.95 |
Next Year | -0.67 |
EPS (TTM) | -1.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.31M | 0.06M | 126.32M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.24 | -0.20 | -0.95 | -0.67 |
# of Estimates | 3 | 2 | 4 | 4 |
Most Recent Consensus | NA | NA | -1.00 | -0.82 |
High Estimate | -0.23 | -0.12 | -0.87 | -0.45 |
Low Estimate | -0.26 | -0.27 | -1.03 | -0.88 |
Year ago EPS | -0.37 | -0.32 | -0.89 | -0.95 |
Year over Year Growth Est. | 35.14% | 37.50% | -6.74% | 29.47% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.24 | -0.20 | -0.95 | -0.67 |
7 Days Ago | -0.24 | -0.20 | -0.95 | -0.67 |
30 Days Ago | -0.24 | -0.20 | -0.95 | -0.67 |
60 Days Ago | -0.31 | -0.30 | -1.08 | -0.79 |
90 Days Ago | -0.31 | -0.30 | -1.08 | -0.79 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.24 | -0.20 | -0.95 | -0.67 |
Zacks Consensus Estimate | -0.24 | -0.20 | -0.95 | -0.67 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.27 | -0.32 | -0.37 | NA |
Estimate | -0.28 | -0.36 | -0.40 | -0.47 | NA |
Difference | 0.06 | 0.09 | 0.08 | 0.10 | 0.08 |
Surprise | 21.43% | 25.00% | 20.00% | 21.28% | 21.93% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more